Review



tc 1 tumor cells  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    ATCC tc 1 tumor cells
    CPQ/GM3 liposomal E7 peptide vaccine retarded <t>the</t> <t>TC-1</t> tumor growth and prolonged the survival of mice. Mice were inoculated with 1x10 TC-1 tumor cells subcutaneously on day 0 and immunized with the indicated E7 vaccine, 2 µg per mouse per injection intramuscularly on day 8 and day 15. A) Average tumor volume. B) Tumor volume on day 36. C) Percentage of mice with tumor diameter under 10mm. Arrows indicate vaccination time points. Error bars show mean ± std. dev. for n = 4 per group. Figure A is analyzed by mixed-effects analysis followed by Tukey's multiple comparisons test. *, **, ***, and **** indicate P ≤ 0.05, 0.01, 0.001, and 0.0001, respectively. Figure B was analyzed by one-way ANOVA with Tukey's multiple comparisons test. Figure C was analyzed by Log-rank (Mantel-Cox) test.
    Tc 1 Tumor Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 514 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tc 1 tumor cells/product/ATCC
    Average 96 stars, based on 514 article reviews
    tc 1 tumor cells - by Bioz Stars, 2026-05
    96/100 stars

    Images

    1) Product Images from "Ganglioside enhances the immunogenicity of nanoparticles displaying short synthetic tumor neoepitopes and epitopes"

    Article Title: Ganglioside enhances the immunogenicity of nanoparticles displaying short synthetic tumor neoepitopes and epitopes

    Journal: Theranostics

    doi: 10.7150/thno.128187

    CPQ/GM3 liposomal E7 peptide vaccine retarded the TC-1 tumor growth and prolonged the survival of mice. Mice were inoculated with 1x10 TC-1 tumor cells subcutaneously on day 0 and immunized with the indicated E7 vaccine, 2 µg per mouse per injection intramuscularly on day 8 and day 15. A) Average tumor volume. B) Tumor volume on day 36. C) Percentage of mice with tumor diameter under 10mm. Arrows indicate vaccination time points. Error bars show mean ± std. dev. for n = 4 per group. Figure A is analyzed by mixed-effects analysis followed by Tukey's multiple comparisons test. *, **, ***, and **** indicate P ≤ 0.05, 0.01, 0.001, and 0.0001, respectively. Figure B was analyzed by one-way ANOVA with Tukey's multiple comparisons test. Figure C was analyzed by Log-rank (Mantel-Cox) test.
    Figure Legend Snippet: CPQ/GM3 liposomal E7 peptide vaccine retarded the TC-1 tumor growth and prolonged the survival of mice. Mice were inoculated with 1x10 TC-1 tumor cells subcutaneously on day 0 and immunized with the indicated E7 vaccine, 2 µg per mouse per injection intramuscularly on day 8 and day 15. A) Average tumor volume. B) Tumor volume on day 36. C) Percentage of mice with tumor diameter under 10mm. Arrows indicate vaccination time points. Error bars show mean ± std. dev. for n = 4 per group. Figure A is analyzed by mixed-effects analysis followed by Tukey's multiple comparisons test. *, **, ***, and **** indicate P ≤ 0.05, 0.01, 0.001, and 0.0001, respectively. Figure B was analyzed by one-way ANOVA with Tukey's multiple comparisons test. Figure C was analyzed by Log-rank (Mantel-Cox) test.

    Techniques Used: Injection



    Similar Products

    tc 1 tumor cells  (ATCC)
    96
    ATCC tc 1 tumor cells
    CPQ/GM3 liposomal E7 peptide vaccine retarded <t>the</t> <t>TC-1</t> tumor growth and prolonged the survival of mice. Mice were inoculated with 1x10 TC-1 tumor cells subcutaneously on day 0 and immunized with the indicated E7 vaccine, 2 µg per mouse per injection intramuscularly on day 8 and day 15. A) Average tumor volume. B) Tumor volume on day 36. C) Percentage of mice with tumor diameter under 10mm. Arrows indicate vaccination time points. Error bars show mean ± std. dev. for n = 4 per group. Figure A is analyzed by mixed-effects analysis followed by Tukey's multiple comparisons test. *, **, ***, and **** indicate P ≤ 0.05, 0.01, 0.001, and 0.0001, respectively. Figure B was analyzed by one-way ANOVA with Tukey's multiple comparisons test. Figure C was analyzed by Log-rank (Mantel-Cox) test.
    Tc 1 Tumor Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tc 1 tumor cells/product/ATCC
    Average 96 stars, based on 1 article reviews
    tc 1 tumor cells - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    murine tumor cell line tc 1  (ATCC)
    96
    ATCC murine tumor cell line tc 1
    CPQ/GM3 liposomal E7 peptide vaccine retarded <t>the</t> <t>TC-1</t> tumor growth and prolonged the survival of mice. Mice were inoculated with 1x10 TC-1 tumor cells subcutaneously on day 0 and immunized with the indicated E7 vaccine, 2 µg per mouse per injection intramuscularly on day 8 and day 15. A) Average tumor volume. B) Tumor volume on day 36. C) Percentage of mice with tumor diameter under 10mm. Arrows indicate vaccination time points. Error bars show mean ± std. dev. for n = 4 per group. Figure A is analyzed by mixed-effects analysis followed by Tukey's multiple comparisons test. *, **, ***, and **** indicate P ≤ 0.05, 0.01, 0.001, and 0.0001, respectively. Figure B was analyzed by one-way ANOVA with Tukey's multiple comparisons test. Figure C was analyzed by Log-rank (Mantel-Cox) test.
    Murine Tumor Cell Line Tc 1, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/murine tumor cell line tc 1/product/ATCC
    Average 96 stars, based on 1 article reviews
    murine tumor cell line tc 1 - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    mouse tc 1 tumor cells  (ATCC)
    96
    ATCC mouse tc 1 tumor cells
    CPQ/GM3 liposomal E7 peptide vaccine retarded <t>the</t> <t>TC-1</t> tumor growth and prolonged the survival of mice. Mice were inoculated with 1x10 TC-1 tumor cells subcutaneously on day 0 and immunized with the indicated E7 vaccine, 2 µg per mouse per injection intramuscularly on day 8 and day 15. A) Average tumor volume. B) Tumor volume on day 36. C) Percentage of mice with tumor diameter under 10mm. Arrows indicate vaccination time points. Error bars show mean ± std. dev. for n = 4 per group. Figure A is analyzed by mixed-effects analysis followed by Tukey's multiple comparisons test. *, **, ***, and **** indicate P ≤ 0.05, 0.01, 0.001, and 0.0001, respectively. Figure B was analyzed by one-way ANOVA with Tukey's multiple comparisons test. Figure C was analyzed by Log-rank (Mantel-Cox) test.
    Mouse Tc 1 Tumor Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse tc 1 tumor cells/product/ATCC
    Average 96 stars, based on 1 article reviews
    mouse tc 1 tumor cells - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    tc 1 lung epithelial tumor cell line  (ATCC)
    96
    ATCC tc 1 lung epithelial tumor cell line
    CPQ/GM3 liposomal E7 peptide vaccine retarded <t>the</t> <t>TC-1</t> tumor growth and prolonged the survival of mice. Mice were inoculated with 1x10 TC-1 tumor cells subcutaneously on day 0 and immunized with the indicated E7 vaccine, 2 µg per mouse per injection intramuscularly on day 8 and day 15. A) Average tumor volume. B) Tumor volume on day 36. C) Percentage of mice with tumor diameter under 10mm. Arrows indicate vaccination time points. Error bars show mean ± std. dev. for n = 4 per group. Figure A is analyzed by mixed-effects analysis followed by Tukey's multiple comparisons test. *, **, ***, and **** indicate P ≤ 0.05, 0.01, 0.001, and 0.0001, respectively. Figure B was analyzed by one-way ANOVA with Tukey's multiple comparisons test. Figure C was analyzed by Log-rank (Mantel-Cox) test.
    Tc 1 Lung Epithelial Tumor Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tc 1 lung epithelial tumor cell line/product/ATCC
    Average 96 stars, based on 1 article reviews
    tc 1 lung epithelial tumor cell line - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    tc 1 tumor cell line  (ATCC)
    96
    ATCC tc 1 tumor cell line
    CPQ/GM3 liposomal E7 peptide vaccine retarded <t>the</t> <t>TC-1</t> tumor growth and prolonged the survival of mice. Mice were inoculated with 1x10 TC-1 tumor cells subcutaneously on day 0 and immunized with the indicated E7 vaccine, 2 µg per mouse per injection intramuscularly on day 8 and day 15. A) Average tumor volume. B) Tumor volume on day 36. C) Percentage of mice with tumor diameter under 10mm. Arrows indicate vaccination time points. Error bars show mean ± std. dev. for n = 4 per group. Figure A is analyzed by mixed-effects analysis followed by Tukey's multiple comparisons test. *, **, ***, and **** indicate P ≤ 0.05, 0.01, 0.001, and 0.0001, respectively. Figure B was analyzed by one-way ANOVA with Tukey's multiple comparisons test. Figure C was analyzed by Log-rank (Mantel-Cox) test.
    Tc 1 Tumor Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tc 1 tumor cell line/product/ATCC
    Average 96 stars, based on 1 article reviews
    tc 1 tumor cell line - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    tc-1-luciferase tumor cell line  (Johns Hopkins HealthCare)
    90
    Johns Hopkins HealthCare tc-1-luciferase tumor cell line
    CPQ/GM3 liposomal E7 peptide vaccine retarded <t>the</t> <t>TC-1</t> tumor growth and prolonged the survival of mice. Mice were inoculated with 1x10 TC-1 tumor cells subcutaneously on day 0 and immunized with the indicated E7 vaccine, 2 µg per mouse per injection intramuscularly on day 8 and day 15. A) Average tumor volume. B) Tumor volume on day 36. C) Percentage of mice with tumor diameter under 10mm. Arrows indicate vaccination time points. Error bars show mean ± std. dev. for n = 4 per group. Figure A is analyzed by mixed-effects analysis followed by Tukey's multiple comparisons test. *, **, ***, and **** indicate P ≤ 0.05, 0.01, 0.001, and 0.0001, respectively. Figure B was analyzed by one-way ANOVA with Tukey's multiple comparisons test. Figure C was analyzed by Log-rank (Mantel-Cox) test.
    Tc 1 Luciferase Tumor Cell Line, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tc-1-luciferase tumor cell line/product/Johns Hopkins HealthCare
    Average 90 stars, based on 1 article reviews
    tc-1-luciferase tumor cell line - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    CPQ/GM3 liposomal E7 peptide vaccine retarded the TC-1 tumor growth and prolonged the survival of mice. Mice were inoculated with 1x10 TC-1 tumor cells subcutaneously on day 0 and immunized with the indicated E7 vaccine, 2 µg per mouse per injection intramuscularly on day 8 and day 15. A) Average tumor volume. B) Tumor volume on day 36. C) Percentage of mice with tumor diameter under 10mm. Arrows indicate vaccination time points. Error bars show mean ± std. dev. for n = 4 per group. Figure A is analyzed by mixed-effects analysis followed by Tukey's multiple comparisons test. *, **, ***, and **** indicate P ≤ 0.05, 0.01, 0.001, and 0.0001, respectively. Figure B was analyzed by one-way ANOVA with Tukey's multiple comparisons test. Figure C was analyzed by Log-rank (Mantel-Cox) test.

    Journal: Theranostics

    Article Title: Ganglioside enhances the immunogenicity of nanoparticles displaying short synthetic tumor neoepitopes and epitopes

    doi: 10.7150/thno.128187

    Figure Lengend Snippet: CPQ/GM3 liposomal E7 peptide vaccine retarded the TC-1 tumor growth and prolonged the survival of mice. Mice were inoculated with 1x10 TC-1 tumor cells subcutaneously on day 0 and immunized with the indicated E7 vaccine, 2 µg per mouse per injection intramuscularly on day 8 and day 15. A) Average tumor volume. B) Tumor volume on day 36. C) Percentage of mice with tumor diameter under 10mm. Arrows indicate vaccination time points. Error bars show mean ± std. dev. for n = 4 per group. Figure A is analyzed by mixed-effects analysis followed by Tukey's multiple comparisons test. *, **, ***, and **** indicate P ≤ 0.05, 0.01, 0.001, and 0.0001, respectively. Figure B was analyzed by one-way ANOVA with Tukey's multiple comparisons test. Figure C was analyzed by Log-rank (Mantel-Cox) test.

    Article Snippet: Renca tumor cells and TC-1 tumor cells were purchased from the ATCC and cultured in Dulbecco's modified Eagle's medium and RPMI medium separately with 10% fetal bovine serum (FBS) and 1% 100 U/mL penicillin and 100 μg/mL streptomycin.

    Techniques: Injection